Abstract
Herpes simplex virus type 1 (HSV-1 ) is a human pathogen whose lifestyle is based on a long-term dual interaction with the infected host, being able to establish both lytic and latent infections. The virus genome is a 153-kilobase pair (kbp) double-stranded DNA molecule encoding more than 80 genes. The interest of HSV-1 as gene transfer vector stems from its ability to infect many different cell types, both quiescent and proliferating cells, the very high packaging capacity of the virus capsid , the outstanding neurotropic adaptations that this virus has evolved, and the fact that it never integrates into the cellular chromosomes, thus avoiding the risk of insertional mutagenesis . Two types of vectors can be derived from HSV-1, recombinant vectors and amplicon vectors, and different methodologies have been developed to prepare large stocks of each type of vector. This chapter summarizes the approach most commonly used to prepare recombinant HSV-1 vectors through homologous recombination , either in eukaryotic cells or in bacteria.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Roizman B, Knipe DM (2001) Herpes simplex viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology. Lippincot, Williams and Wilkins, Philadelphia, PA, pp 2399–2460
Marozin S, Prank U, Sodeik B (2004) Herpes simplex virus type 1 infection of polarized epithelial cells requires microtubules and access to receptors present at cell–cell contact sites. J Gen Virol 85:775–786
Honess RW, Roizman B (1975) Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides. Proc Natl Acad Sci U S A 72:1276–1280
Batterson W, Roizman B (1983) Characterization of the herpes simplex virion-associated factor responsible for the induction of alpha genes. J Virol 46:371–377
Skepper JN, Whiteley A, Browne H et al (2001) Herpes simplex virus nucleocapsids mature to progeny virions by an envelopment → deenvelopment → reenvelopment pathway. J Virol 75:5697–5702
Deshmane SL, Fraser NW (1989) During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. Virol 63:943–947
Farrell MJ, Dobson AT, Feldman LT (1991) Herpes simplex virus latency-associated transcript is a stable intron. Proc Natl Acad Sci U S A 88:790–794
Umbach JL, Kramer MF, Jurak I et al (2008) MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454:780–783
Preston CM (2000) Repression of viral transcription during herpes simplex virus latency. J Gen Virol 8:1–19
Manservigi R, Argnani R, Marconi P et al (2007) Herpesvirus-based vectors for gene transfer, gene therapy, and the development of novel vaccines. In: Hefferon KL (ed) Virus expression vectors. Transworld Research Network, Kerala, India, pp 205–246
Krisky DM, Marconi PC, Oligino TJ et al (1998) Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications. Gene Ther 5:1517–1530
Wu N, Watkins SC, Schaffer PA et al (1996) Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J Virol 70:6358–6369
Samaniego LA, Neiderhiser L, DeLuca NA (1998) Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J Virol 72:3307–3320
Berto E, Bozac A, Marconi P (2005) Development and application of replication-incompetent HSV-1-based vectors. Gene Ther 12(Suppl 1):S98–S102
Krisky DM, Wolfe D, Goins WF et al (1998) Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther 5:1593–1603
Wolfe D, Mata M, Fink DJ (2009) A human trial of HSV-mediated gene transfer for the treatment of chronic pain. Gene Ther 16:455–460
Advani SJ, Weischelbaum RR, Whitley RJ et al (2002) Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications. Clin Microbiol Infect 8:551–563
Argnani R, Lufino M, Manservigi M et al (2005) Replication-competent herpes simplex vectors: design and applications. Gene Ther 12(Suppl 1):S170–S177
Nawa A, Luo C, Zhang L et al (2008) Non-engineered, naturally oncolytic herpes simplex virus HSV1 HF-10: applications for cancer gene therapy. Curr Gene Ther 8:208–221
Gage PJ, Sauer B, Levine M et al (1992) A cell-free recombination system for site-specific integration of multigenic shuttle plasmids into the herpes simplex virus type 1 genome. J Virol 66:5509–5515
Rinaldi A, Marshall KR, Preston CM (1999) A non-cytotoxic herpes simplex virus vector which expresses Cre recombinase directs efficient site-specific recombination. Virus Res 65:11–20
Stricklett PK, Nelson RD, Kohan DE (1998) Site-specific recombination using an epitope tagged bacteriophage P1 Cre recombinase. Gene 215:415–423
Krisky DM, Marconi PC, Oligino T et al (1997) Rapid method for construction of recombinant HSV gene transfer vectors. Gene Ther 4:1120–1125
Saeki Y, Ichikawa T, Saeki A et al (1998) Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors. Human Gene Ther 9:2787–2794
Tanaka M, Kagawa H, Yamanashi Y et al (2003) Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo. J Virol 77:1382–1391
Warming S, Costantino N, Court DL et al (2005) Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res 33:e36
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Marconi, P., Fraefel, C., Epstein, A.L. (2015). Herpes Simplex Virus Type 1 (HSV-1 )-Derived Recombinant Vectors for Gene Transfer and Gene Therapy . In: Lossi, L., Merighi, A. (eds) Neuronal Cell Death. Methods in Molecular Biology, vol 1254. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2152-2_20
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2152-2_20
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2151-5
Online ISBN: 978-1-4939-2152-2
eBook Packages: Springer Protocols